Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/8632427

J. Med. Chem. 1996 Mar 15 39 6 1210-9

Download in:

View as

General Info

PMID
8632427